Applied DNA Sciences Inc (APDN) reported quarterly earnings results on Thursday, May-12-2016. The company reported $-0.14 earnings per share for the quarter, missing the analyst consensus estimate by $-0.04. Analysts had a consensus of $-0.10. The company posted revenue of $.60 million in the period, compared to analysts expectations of $1.80 million. The company’s revenue was down -60.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $-0.11 EPS.
Applied DNA Sciences Inc opened for trading at $2.98 and hit $3.111 on the upside on Tuesday, eventually ending the session at $3.11, with a gain of 4.01% or 0.12 points. The heightened volatility saw the trading volume jump to 56,103 shares. Company has a market cap of $75 M.
In a different news, on Mar 6, 2015, John Iii Bitzer (director) purchased 76,923 shares at $3.24 per share price.
Applied DNA Sciences Inc. provides plant-based deoxyribonucleic acid (DNA) security and authentication solutions and services that help protect products brands supply chains and intellectual property of companies governments and consumers from theft counterfeiting fraud and diversion. The Company is also engaged in the production of specific DNA sequences using the polymerase chain reaction (PCR). The Company’s product solutions are SigNature DNA SigNature T DNA fiberTyping DNAnet Sentry digitalDNA and SmokeCloak DNA. Its product solutions are used in various industries including microcircuits and other electronics cash-in-transit (transport and storage of banknotes) textiles and apparel home asset marking automotive printing and packaging homeland security law enforcement identity cards and other secure documents industrial materials agrochemicals pharmaceuticals consumer products food and beverage fine wine and art and collectibles.